Spironolactone Tablet, Coated
Product Images NDC 70518-3655

9 FDA label images from Remedyrepack Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Spironolactone (NDC 70518-3655). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

20 (Spironolactone Tablets Usp 1)

20 (Spironolactone Tablets Usp 1)
Chemical structure of spironolactone, a steroidal compound depicted with its characteristic rings and functional groups, including a lactone and thioacetate moiety, corresponding to the active ingredient spironolactone.*
FDA Label Image

Figure 1 (Figure1)

Figure 1 (Figure1)
A Kaplan-Meier survival curve comparing the probability of an event over time in months between Spironolactone (n=822) and placebo (n=841) groups. The graph shows higher survival probability for Spironolactone. The log-rank test p-value is less than 0.001, indicating significant difference between groups.*
FDA Label Image

Figure 2 (Figure2)

Figure 2 (Figure2)
A forest plot displaying hazard ratios (HR) and 95% confidence intervals (CI) across various subgroups comparing Spironolactone 50 mg coated tablets with placebo. Subgroups include age, sex, race, LVEF percentage, heart failure type, NYHA class, diabetes status, serum creatinine, creatinine clearance, potassium levels, digoxin, ACE inhibitor, and beta blocker use. The plot shows the distribution of HR values and sample sizes for each subgroup.*
FDA Label Image

Mm1 (Spironolactone 50mg 70518 3655 00)

Mm1 (Spironolactone 50mg 70518 3655 00)
Spironolactone 50 mg coated tablet label showing a quantity of 30 tablets. The label includes the NDC number 70518-3655-00 and indicates the product is repackaged by RemedyRepack Inc. It references Oxford Pharmaceuticals as the manufacturer and provides storage instructions. Marked Rx only, the tablet is described as oval and white.*
FDA Label Image

Mm2 (Spironolactone 50mg 70518 3655 01)

Mm2 (Spironolactone 50mg 70518 3655 01)
Spironolactone 50 mg coated tablets packaging label showing quantity of 90 tablets. The label includes NDC 70518-3655-01, is marked RX Only, and indicates repackaging by RemedyRepack Inc. It also displays storage instructions, manufacturer information (Oxford Pharmaceuticals, LLC), and a QR code.*
FDA Label Image

Mm3 (Spironolactone 50mg 70518 3655 02)

Mm3 (Spironolactone 50mg 70518 3655 02)
Spironolactone 50 mg coated tablets packaging label showing a quantity of 30 tablets. The label lists the NDC number 70518-3655-02 and states the tablets are oval, white. The product is repackaged by RemedyRepack Inc., Indiana, PA, with contact information. Manufacturer listed is Oxford Pharmaceuticals, LLC, Birmingham, AL. Storage and dosage instructions are partially visible.*
FDA Label Image

Mm4 (Spironolactone 50mg 70518 3655 03)

Mm4 (Spironolactone 50mg 70518 3655 03)
This is a packaging label for Spironolactone 50 mg coated tablets supplied by RemedyRepack Inc. The box contains 100 tablets. The manufacturer is Oxford Pharmaceuticals, LLC, Birmingham, AL. The label includes storage instructions and a note to see the insert for usual dosage.*
FDA Label Image

Mm5 (Spironolactone 50mg 70518 3655 04)

Mm5 (Spironolactone 50mg 70518 3655 04)
Spironolactone Tablet 50 mg coated oral tablet, single count packaging. The label shows NDC 70518-3655-04, repackaged by RemedyRepack Inc., Indiana, PA. Manufacturer is Oxford Pharmaceuticals, LLC, Birmingham, AL. Storage instructions include temperature ranges and keeping medication out of reach of children.*
FDA Label Image

Mm6 (Spironolactone 50mg 70518 3655 05)

Mm6 (Spironolactone 50mg 70518 3655 05)
Spironolactone 50 mg coated tablets packaging label showing quantity of 30 tablets. The label includes the NDC number 70518-3655-05 and indicates the product is repackaged by RemedyRepack Inc. Additional manufacturer information states Oxford Pharmaceuticals, LLC, Birmingham, AL. Storage instructions and safety warnings are also partially visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.